Evidence map›Paper›PMID 37443639›Full record

ArticleDiagnostics (Basel, Switzerland)2023

SARS-CoV-2 Testing of Emergency Department Patients Using cobas

Renate Egerer, Birgit Edel, Franziska Hornung, Stefanie Deinhardt-Emmer, Michael Baier, Jan-Christoph Lewejohann, Wolfgang Pfister, Bettina Löffler, Jürgen Rödel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Renate EgererInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Birgit EdelInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Franziska HornungInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Stefanie Deinhardt-EmmerInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.ORCID 0000-0003-4495-4052
Michael BaierInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.ORCID 0000-0002-3625-1544
Jan-Christoph LewejohannDepartment of Emergency Medicine, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Wolfgang PfisterDepartment of Hospital Hygiene, Sophien- und Hufeland-Klinikum, 99425 Weimar, Germany.
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Jürgen RödelInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Jena University Hospital · DESophien-und Hufeland Klinikum · DE

Funding

Federal Ministry of Education and Research 13N15745
6 · The paper itself

Abstract

Rapid testing for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) of patients presenting to emergency departments (EDs) facilitates the decision for isolation on admission to hospital wards. Differences in the sensitivity of molecular assays have implications for diagnostic workflows. This study evaluated the performance of the cobas

Indexed as

emergency departmentPOCrapid diagnostic testSARS-CoV-2

Identifiers

PMID37443639
PMCPMC10341290
OpenAlexW4382982139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.